On Tuesday, Twist Bioscience Corp (NASDAQ: TWST) was -2.73% drop from the session before settling in for the closing price of $57.44. A 52-week range for TWST has been $14.42 – $60.90.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 60.13% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 17.15%. With a float of $55.73 million, this company’s outstanding shares have now reached $57.56 million.
In an organization with 919 employees, it is important to assess its efficiency.
Twist Bioscience Corp (TWST) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Twist Bioscience Corp stocks. The insider ownership of Twist Bioscience Corp is 4.29%, while institutional ownership is 114.20%. The most recent insider transaction that took place on Jul 23 ’24, was worth 124,971. In this transaction President and COO of this company sold 2,207 shares at a rate of $56.62, taking the stock ownership to the 171,212 shares. Before that another transaction happened on Jul 09 ’24, when Company’s Chief Financial Officer sold 842 for $48.91, making the entire transaction worth $41,185. This insider now owns 73,602 shares in total.
Twist Bioscience Corp (TWST) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 17.15% per share during the next fiscal year.
Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators
You can see what Twist Bioscience Corp (TWST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.35, a number that is poised to hit -0.76 in the next quarter and is forecasted to reach -2.49 in one year’s time.
Technical Analysis of Twist Bioscience Corp (TWST)
Let’s dig in a bit further. During the last 5-days, its volume was 0.91 million. That was inferior than the volume of 1.03 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 57.64%. Additionally, its Average True Range was 3.29.
During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 84.98%, which indicates a significant increase from 45.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.33% in the past 14 days, which was lower than the 68.82% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $49.98, while its 200-day Moving Average is $36.03. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $57.79. Second resistance stands at $59.72. The third major resistance level sits at $61.23. If the price goes on to break the first support level at $54.35, it is likely to go to the next support level at $52.84. Assuming the price breaks the second support level, the third support level stands at $50.91.
Twist Bioscience Corp (NASDAQ: TWST) Key Stats
There are 58,226K outstanding shares of the company, which has a market capitalization of 3.25 billion. As of now, sales total 245,110 K while income totals -204,620 K. Its latest quarter income was 75,300 K while its last quarter net income were -45,490 K.
